Ubs Group Ag Panbela Therapeutics, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$0.07 - $6528.0 $1,610 - $150 Million
23,005 Added 12.08%
213,498 $14,000
Q3 2022

Nov 10, 2022
BUY
$0.24 - $8712.0 $45,620 - $1.66 Billion
190,085 Added 46589.46%
190,493 $51,000
Q2 2022

Aug 10, 2022
BUY
$0.61 - $2.1 $248 - $856
408 New
408 $0

Others Institutions Holding PBLA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Panbela Therapeutics, Inc.

PBLA Quotes by TradingView
  • Ticker PBLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,774,000
  • Market Cap $7.69M
  • Description
  • Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer...
More about PBLA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email